Skip to main content
. 2017 Dec 29;23(1):79. doi: 10.3390/molecules23010079

Figure 5.

Figure 5

The ELISA challenges and evolving solutions. We show the strengths and limitations of this immunoassay and the pre-treatment possibilities to overcome the limitations.